Skip to main content
SpringerLink
Log in

Is Helicobacter pylori eradication therapy cost effective?

  • Drug Economics and Quality of Life
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Soll AD, on behalf of the Practice Parameters Committee of the American College of Gastroenterology. Medical treatment of peptic ulcer disease. Practice guidelines. JAMA 1996 Feb 28; 275(8): 622–9

    Article  PubMed  CAS  Google Scholar 

  2. Guidelines for the eradication of Helicobacter pylori: why, who and what? Drug Ther Perspect 1996 Apr 29; 7(8): 7–10

    Google Scholar 

  3. European guidelines on H. pylori eradication. Drug Ther Perspect 1996 Dec 9; 8(12): 5

    Google Scholar 

  4. Bell GD, Powell KU, Bolton G, et al. Clinical and pharmacoeconomic evaluation of management strategies for duodenal ulcer disease. Br J Med Econ 1993; 6: 45–58

    Google Scholar 

  5. Carrere M-O, Lamouliatte H, Ruszniewski P. Is Helicobacter pylori eradication a cost-effective treatment of duodenal ulcer disease? Pharmacoeconomics 1997 Mar; 11(3): 216–24

    Article  PubMed  CAS  Google Scholar 

  6. Sonnenberg A, Townsend WF. Costs of duodenal ulcer therapy with antibiotics. Arch Intern Med 1995; 155: 299–8

    Article  Google Scholar 

  7. O’Brien B, Goere R, Mohamed H, et al. Cost-effectiveness of Helicobacter pylori eradication for the long-term management of duodenal ulcer in Canada. Arch Intern Med 1995; 155: 1958–64

    Article  PubMed  Google Scholar 

  8. Unge P, Jonsson B, Stalhammar NO. The cost-effectiveness of Helicobacter-pylori eradication versus maintenance and episodic treatment in duodenal ulcer patients in Sweden. Pharmacoeconomics 1995; 8: 410–27

    Article  PubMed  CAS  Google Scholar 

  9. Fendrick AM, Chernew ME, Hirth RA, et al. Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995; 123: 260–8

    PubMed  CAS  Google Scholar 

  10. Breuer T, Graham DY. Can the urea-breath-test be challenged by endoscopy as first line diagnostic tool? A cost effective analysis based on antibiotic resistance against initial treatment choice. Gut 1997; 41 (Suppl. 1): 127

    Google Scholar 

  11. Vakil N, Cost-effectiveness of H. pylori eradication regimens: efficacy vs effectiveness. Gut 1997; 41 (Suppl. 1): 89

    Google Scholar 

  12. Cottril MRB. The prevalence of Helicobacter pylori infection in patients receiving long-term H2-receptor antagonists in general practice: clinical and financial consequences of eradication using omeprazole plus amoxycillin or triple therapy. Br J Med Econ 1994; 7: 35–41

    Google Scholar 

  13. Powell KU, Bell GD, Bolton GH, et al. Helicobacter pylori eradication in patients with peptic ulcer disease: clinical consequences and financial implications. Q J Med 1994; 87: 283–90

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Is Helicobacter pylori eradication therapy cost effective?. Drugs Ther. Perspect 10, 13–16 (1997). https://doi.org/10.2165/00042310-199710120-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-199710120-00005

Search

Navigation